These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4752123)

  • 1. Phosphorus--nitrogen compounds. XV. N-1-adamantylphosphoramidic dichloride and dimethyl and diphenyl N-1-adamantylphosphoramidate.
    Cates LA; Gallio RL; Cramer MB
    J Pharm Sci; 1973 Oct; 62(10):1719-20. PubMed ID: 4752123
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological study of amantadine, a new antiparkinson drug].
    Mori J; Sato Y; Oashi T; Hitomi M
    Nihon Yakurigaku Zasshi; 1974 Jan; 70(1):119-26. PubMed ID: 4858046
    [No Abstract]   [Full Text] [Related]  

  • 3. Phosphorus-nitrogen compounds XVI: phosphoramantadine derivatives.
    Cates LA; Gallio RL
    J Pharm Sci; 1974 Sep; 63(9):1480-2. PubMed ID: 4427279
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and anticancer activity of 2-substituted 2,3-dihydro-1,3,2- benzoxazaphosphorin-4-one and its 2-oxide derivatives.
    Kostka K; Porada M; Graczyk J
    Arch Pharm (Weinheim); 1994 Apr; 327(4):233-6. PubMed ID: 8204022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-anti-Parkinson activity relationships in the aminoadamantanes. Influence of bridgehead substitution.
    Henkel JG; Hane JT; Gianutsos G
    J Med Chem; 1982 Jan; 25(1):51-6. PubMed ID: 7086822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression by amantadine of drug-induced rigidity in the rat.
    Jurna I; Grossmann W; Nell T
    Neuropharmacology; 1972 Jul; 11(4):559-64. PubMed ID: 5047944
    [No Abstract]   [Full Text] [Related]  

  • 7. Central nervous system and autonomic nervous system effects of amantadine and of some standard anti-Parkinson drugs.
    Bianchi C; Tomasi L
    Pharmacology; 1973; 10(4):226-37. PubMed ID: 4148634
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and pharmacological properties of 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-1,2-dialkylpyrrolidine derivatives.
    Umio S; Hitomi M; Nojima H; Kumadaki N; Ueda I; Kanaya T; Deguchi Y
    J Med Chem; 1972 Sep; 15(9):891-4. PubMed ID: 4403249
    [No Abstract]   [Full Text] [Related]  

  • 9. Phosphorohydrazines of 4-oxo-4H-1-benzopyran and 1-benzopyran-2,4-dione exhibit antitumor activity against L1210 leukemia.
    Nawrot-Modranka J; Ochocki J; Graczyk J
    Pharmazie; 2004 Sep; 59(9):731-2. PubMed ID: 15497762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide. Complete inhibition of murine leukemia L1210 in vivo by a Fenton oxidation product.
    Struck RF; Thorpe MC; Coburn WC; Laster WR
    J Am Chem Soc; 1974 Jan; 96(1):313-5. PubMed ID: 4810573
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.
    Svensson TH
    Eur J Pharmacol; 1973 Sep; 23(3):232-8. PubMed ID: 4746740
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphorus-nitrogen compounds. 13. Methoxyethyl and propylamine derivatives.
    Ryu EK; Cates LA
    J Med Chem; 1971 Oct; 14(10):1022. PubMed ID: 5115687
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of amantadine on vegetative state after traumatic brain injury: a functional magnetic resonance imaging study.
    Chen X; Tang C; Zhou H; Li Z
    J Int Med Res; 2019 Feb; 47(2):1015-1024. PubMed ID: 30514146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential anticancer agents. 10. Synthesis of N-(4((2,4-diamino-7-pteridyl)methyl)-N10-methylamino)benzoyl)glutamic acid.
    Suster DC; Feyns VL; Ciustea G; Botez G; Dobre V; Bick R; Niculescu-Duvăz I
    J Med Chem; 1974 Jul; 17(7):758-60. PubMed ID: 4836410
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synthesis and pharmacologic examination of derivatives of benzoxazaphosphoryl-4-one and 2-phenyl-10-methyl-3a-triethoxyphosphone-1H,2,3,9,10-tetrahydropyrrolo [3,4-b][1,4]benzoxazepine-1,3,9-trione].
    Porada M; Budzisz E; Graczyk J; Pakulska W
    Acta Pol Pharm; 1993; 50(2-3):173-8. PubMed ID: 8030424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological screening of 1-chloro-3-(2-propynyloxy)-2-propanols and 2-((2-propynyloxy)methyl)oxiranes.
    Fugitt RB; Wu GS; Martinelli LC
    J Pharm Sci; 1973 Nov; 62(11):1894-6. PubMed ID: 4758098
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.
    Moyer JD; Handschumacher RE
    Cancer Res; 1979 Aug; 39(8):3089-94. PubMed ID: 455293
    [No Abstract]   [Full Text] [Related]  

  • 18. The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way.
    Stoof JC; Booij J; Drukarch B; Wolters EC
    Eur J Pharmacol; 1992 Mar; 213(3):439-43. PubMed ID: 1618282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical effects of adamatanamines, a new class of drugs with antiparkinson activity.
    Wesemann W; Schollmeyer JD
    Agents Actions; 1973 Oct; 3(3):195. PubMed ID: 4784450
    [No Abstract]   [Full Text] [Related]  

  • 20. 1-[4-(4,5-dihydro-1H-imidazol-2-yl)aminophenyl]-3-(substituted phenyl)-2-propene-1-one as antiparkinsonian agents.
    Srivastava VK; Singh S; Palit G; Shanker K
    Pharmazie; 1986 Aug; 41(8):598-9. PubMed ID: 3786386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.